$2.54
-0.32-11.19%
At close: -
$4.50
1.9677.17%
After Hours: Dec 19, 4:00 PM EDT
Comments
Loading...
Latest Relief Therapeutics Stock News | OTC:RLFTF | Benzinga
Get the latest news on Relief Therapeutics stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Relief Therapeutics performance
Categories: All
Friday, March 22, 2024
Monday, November 14, 2022
Thursday, July 28, 2022
Friday, July 01, 2022
Tuesday, June 21, 2022
Sunday, June 05, 2022
Tuesday, May 31, 2022
Thursday, January 13, 2022
Wednesday, January 12, 2022
Tuesday, December 14, 2021
Wednesday, November 24, 2021
Friday, November 05, 2021
Wednesday, October 27, 2021
Wednesday, October 06, 2021
- The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
- Acer Therapeutics Stock Jumps As UCD Candidate Is Under FDA Review
- Acer Therapeutics and Relief Therapeutics Announced FDA Acceptance for Filing of New Drug Application for ACER-001 to Treat Urea Cycle Disorders With PDUFA Target Action Date of June 5, 2022